195 related articles for article (PubMed ID: 26185040)
1. Hepatitis B revaccination in HIV-infected vaccine non-responders: is double dosing always necessary?
Chatkittikunwong G; Khawcharoenporn T
Int J STD AIDS; 2016 Sep; 27(10):850-5. PubMed ID: 26185040
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients.
Psevdos G; Kim JH; Groce V; Sharp V
AIDS Patient Care STDS; 2010 Jul; 24(7):403-7. PubMed ID: 20586648
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.
Pettit NN; DePestel DD; Malani PN; Riddell J
HIV Clin Trials; 2010; 11(6):332-9. PubMed ID: 21239361
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
[TBL] [Abstract][Full Text] [Related]
7. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
[TBL] [Abstract][Full Text] [Related]
9. Double-dose hepatitis B revaccination in nonresponsive HIV-infected adolescents.
Bunupuradah T; Ananworanich J; Puthanakit T
J Int Assoc Provid AIDS Care; 2013; 12(3):157-8. PubMed ID: 23422743
[TBL] [Abstract][Full Text] [Related]
10. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
[TBL] [Abstract][Full Text] [Related]
11. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
Irungu E; Mugo N; Ngure K; Njuguna R; Celum C; Farquhar C; Dhanireddy S; Baeten JM
J Infect Dis; 2013 Feb; 207(3):402-10. PubMed ID: 23175769
[TBL] [Abstract][Full Text] [Related]
12. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial.
Raven SFH; Hoebe CJPA; Vossen ACTM; Visser LG; Hautvast JLA; Roukens AHE; van Steenbergen JE
Lancet Infect Dis; 2020 Jan; 20(1):92-101. PubMed ID: 31629649
[TBL] [Abstract][Full Text] [Related]
13. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
[TBL] [Abstract][Full Text] [Related]
14. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
de Vries-Sluijs TE; Hansen BE; van Doornum GJ; Springeling T; Evertsz NM; de Man RA; van der Ende ME
J Infect Dis; 2008 Jan; 197(2):292-4. PubMed ID: 18177248
[TBL] [Abstract][Full Text] [Related]
15. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
16. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
18. Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule.
Han K; Shao X; Zheng H; Wu C; Zhu J; Zheng X; Zhang Y
Hum Vaccin Immunother; 2012 Dec; 8(12):1845-9. PubMed ID: 22906933
[TBL] [Abstract][Full Text] [Related]
19. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
